A Search Service for Abbreviation / Long Form

■検索結果 - 略語 : IBS-D

検索条件

検索語：IBS-D

検索方法：完全一致

主な研究分野:

結果

略語: IBS-D

出現頻度: 712

対応する展開形の数: 43

No.

展開形

主な研究分野

共起略語

PubMed/MEDLINE情報 (発表年, 題目)

irritable bowel syndrome

(腹痛と便通異常が慢性的に持続する腸管の機能性疾患) 過敏性腸症候群, 過敏性大腸症候群

(332回)

Gastroenterology

胃腸病学

(73回)

AWR(29回)

IBS-SSS(28回)

IBS(24回)

2004Rectal hypersensitivity reduced by acupoint TENS in patients with diarrhea-predominant irritable bowel syndrome: a pilot study.

irritable bowel syndrome with diarrhea

(151回)

Gastroenterology

胃腸病学

(69回)

GI(10回)

IBS(9回)

BAD(6回)

2008Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome.

IBS with diarrhea

(87回)

Gastroenterology

胃腸病学

(39回)

IBS(80回)

IBS-C(33回)

IBS-M(10回)

2004Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.

IBS-diarrhea

(21回)

Gastroenterology

胃腸病学

(13回)

IBS(18回)

IBS-C(12回)

IBS-M(6回)

2010Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria.

IBS with predominant diarrhea

(19回)

Gastroenterology

胃腸病学

(9回)

IBS(16回)

IBS-C(7回)

QoL(3回)

2008Lower gastrointestinal disorders in patients with irritable bowel syndrome.

irritable bowel syndrome with predominant diarrhea

(14回)

Gastroenterology

胃腸病学

(4回)

BAs(2回)

FD(2回)

FMT(2回)

2014Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study.

IBS-diarrhea dominant

(13回)

Gastroenterology

胃腸病学

(6回)

IBS(13回)

IBS-C(5回)

CI(2回)

2000An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome.

IBS patients with diarrhoea

(12回)

Gastroenterology

胃腸病学

(7回)

IBS(9回)

5-HT(1回)

ACTH(1回)

2002Irritable bowel syndrome neuropharmacology. A review of approved and investigational compounds.

irritable bowel syndrome with diarrhoea predominance

(11回)

Complementary Therapies

補完医療, 補完療法

(2回)

IBS(3回)

IBS-C(2回)

5-HIAA(1回)

2005Cilansetron: a new serotonergic agent for the irritable bowel syndrome with diarrhoea.

IBS and diarrhea

(7回)

Gastroenterology

胃腸病学

(4回)

IBS(5回)

IBS-C(2回)

BA(1回)

2011Treatment of IBS-D with 5-HT3 receptor antagonists vs spasmolytic agents: similar therapeutical effects from heterogeneous pharmacological targets.

Irritable Bowel Syndrome in Adults

(5回)

Gastroenterology

胃腸病学

(5回)

CI(1回)

2019AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).

irritable bowel syndrome complicated with diarrhea

(3回)

Gastroenterology

胃腸病学

(2回)

LHBT(2回)

LI(2回)

LM(2回)

2013Lactose intolerance in irritable bowel syndrome patients with diarrhoea: the roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity.

IBS patients with predominant diarrhea

(3回)

Food

(3回)

GI(3回)

IBS(3回)

LFD(3回)

2021The Relationship between Low Serum Vitamin D Levels and Altered Intestinal Barrier Function in Patients with IBS Diarrhoea Undergoing a Long-Term Low-FODMAP Diet: Novel Observations from a Clinical Trial.

predominant-irritable bowel syndrome

(2回)

Food

(1回)

GI(1回)

HCs(1回)

IBS(1回)

2021Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms.

irritable bowel disease

(2回)

Gastrointestinal Diseases

(1回)

FCP(1回)

HADS(1回)

HC(1回)

2018Optimal cut-off value of fecal calprotectin for the evaluation of ulcerative colitis: An unsolved issue?

predominant-IBS

(2回)

Microbiological Phenomena

(1回)

IBS(2回)

nucleatum(1回)

IBS-QOF(1回)

2020Fusobacterium nucleatum Causes Microbial Dysbiosis and Exacerbates Visceral Hypersensitivity in a Colonization-Independent Manner.

IBS patients of the diarrhea-predominant

(2回)

Gastroenterology

胃腸病学

(2回)

IBS(2回)

UC(1回)

Irritable Bowel Syndrome IBS

(1回)

Medicine

医学, 医薬

(1回)

2010Diarrhea Predominant Irritable Bowel Syndrome (IBS-D): fact or fiction.

IBS-diarrhoea predominant subtype

(1回)

Family Practice

(1回)

CR(1回)

IBS(1回)

IBS-QOL(1回)

2019Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?

Its most common subtype is accompanied with diarrhea

(1回)

Pharmacology

薬理学, 薬理, 薬品作用学

(1回)

ACh(1回)

ENS(1回)

IBS(1回)

2022Patchouli alcohol improved diarrhea-predominant irritable bowel syndrome by regulating excitatory neurotransmission in the myenteric plexus of rats.